Corcept Therapeutics (CORT) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $113.01 -3.82%
EPS Growth %: +406.3%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +406.3%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.24, $0.01 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $87.67 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
